Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 16/20 | 0.77 |
| ▸ | KCNH2 | Q12809 | 13/20 | 0.77 |
| ▸ | PDE4B | Q07343 | 5/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 5/20 | 0.49 |
| ▸ | PDE4C | Q08493 | 4/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5341194 | 0.91 | PDE4A (0.78) | PDE4AKCNH2PDE4BPDE4DPDE4C | |
| SCHEMBL5339663 | 0.90 | PDE4A (0.76) | PDE4AKCNH2PDE4BPDE4DPDE4C | |
| SCHEMBL5335654 | 0.87 | PDE4A (1.00) | PDE4AKCNH2PDE4BPDE4DPDE4C | |
| SCHEMBL6135868 | 0.83 | KCNH2 (0.71) | PDE4AKCNH2PDE4BPDE4DPDE4C | |
| SCHEMBL6136063 | 0.82 | PDE4A (0.75) | PDE4AKCNH2PDE4BPDE4DPDE4C | |
| SCHEMBL6135714 | 0.81 | PDE4A (0.64) | PDE4AKCNH2PDE4BPDE4DPDE4C | |
| SCHEMBL1565705 | 0.78 | PDE4A (1.00) | PDE4AKCNH2PDE4BPDE4DPDE4C | |
| SCHEMBL14347488 | 0.78 | KCNH2 (0.65) | PDE4AKCNH2PDE4BPDE4DPDE4C | |
| SCHEMBL5336761 | 0.77 | PDE4A (0.76) | PDE4AKCNH2PDE4BPDE4DPDE4C | |
| SCHEMBL5342005 | 0.76 | PDE4A (0.72) | PDE4AKCNH2PDE4BPDE4DPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1592419-A1 | USE OF PHOSPHODIESTERASE-4 INHIBITORS AS ENHANCERS OF COGNITION | Merck Frosst Canada & Co. (CA) | 2005-11-09 | — | — | EP | claimed |
| WO-2004047836-A1 | USE OF PHOSPHODIESTERASE-4 INHIBITORS AS ENHANCERS OF COGNITION | MERCK FROSST CANADA & CO. (CA) | 2004-06-10 | — | — | WO | claimed |
| EP-1592419-A1 | USE OF PHOSPHODIESTERASE-4 INHIBITORS AS ENHANCERS OF COGNITION | Merck Frosst Canada & Co. (CA) | 2005-11-09 | — | — | EP | disclosed |
| WO-2004047836-A1 | USE OF PHOSPHODIESTERASE-4 INHIBITORS AS ENHANCERS OF COGNITION | MERCK FROSST CANADA & CO. (CA) | 2004-06-10 | — | — | WO | disclosed |
| EP-1397359-A1 | 1-BIARYL-1,8-NAPTHYRIDIN-4-ONE PHOSPHODIESTERASE-4 INHIBITORS | Merck Frosst Canada & Co. (CA) | 2004-03-17 | — | — | EP | disclosed |
| WO-2002094823-A1 | 1-BIARYL-1,8-NAPTHYRIDIN-4-ONE PHOSPHODIESTERASE-4 INHIBITORS | MERCK FROSST CANADA & CO. (CA) | 2002-11-28 | — | — | WO | disclosed |